ProfileGDS4132 / 218901_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 28% 28% 27% 33% 25% 36% 38% 34% 46% 32% 44% 45% 40% 43% 46% 53% 53% 33% 30% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10167.73528
GSM201543Muscle PCOS pioglitazone 12159.308628
GSM201544Muscle PCOS pioglitazone 16168.000227
GSM201545Muscle PCOS pioglitazone 20191.893633
GSM201829Muscle PCOS pioglitazone 23161.833525
GSM201830Muscle PCOS pioglitazon 25196.396536
GSM201831Muscle PCOS pioglitazone 27196.400838
GSM201832Muscle PCOS pioglitazone 3185.055134
GSM201833Muscle PCOS pioglitazone 41113.23546
GSM201834Muscle PCOS pioglitazone 8176.34932
GSM201835Muscle PCOS after pioglitazone 102100.4244
GSM201836Muscle PCOS after pioglitazone 122108.09945
GSM201837Muscle PCOS after pioglitazone 16287.690840
GSM201838Muscle PCOS after pioglitazone 202102.64843
GSM201839Muscle PCOS after pioglitazone 232113.70446
GSM201840Muscle PCOS after pioglitazone 252141.75653
GSM201841Muscle PCOS after pioglitazone 272129.553
GSM201842Muscle PCOS after pioglitazone 3266.455633
GSM201843Muscle PCOS after pioglitazone 4272.486730
GSM201844Muscle PCOS after pioglitazone 82107.03543